Express Pharma
Home  »  Archive  »  Page 249
Browsing Category

Archive

Towards sustainable CSR

Companies will need to part with two per cent of their precious profits to fund their CSR programmes, if the new provisions of the…

The case of market-based pricing

Normative practice of pricing patented articles including medicines dictates a perfect use of TRIPs flexibilities via CL. This…